Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iMATRIXcobi: Cobimetinib in Pediatric Solid Tumors
NCT02639546Phase 2Completed
- Sponsor
- Roche
- Start
- May 2016
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of cobimetinib in solid tumor, glioma, rhabdomyosarcoma (RMS), neuroblastoma, melanoma, sponsored by Roche. Started May 2016; status: completed.
02
Drugs
cobimetinib
03
Conditions
solid tumorgliomarhabdomyosarcoma (RMS)neuroblastomamelanoma
Beyond the preview
Go deeper on NCT02639546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02639546.